Skip to main content

Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

Volume 18, Number 29, October 2011

Articles

Squalene Synthase Inhibitors: An Update on the Search for New Antihyperlipidemic and Antiatherosclerotic Agents
pp. 4418-4439(22)
Authors: P. Kourounakis, A.; G. Katselou, M.; N. Matralis, A.; M. Ladopoulou, E.; Bavavea, E.

Favourites:
ADD

Clinical Trial Update and Novel Therapeutic Approaches for Metastatic Prostate Cancer
pp. 4440-4453(14)
Authors: Larsson, R.; P. Mongan, N.; Johansson, M.; Shcherbina, L.; Abrahamsson, P.-A.; J. Gudas, L.; Sterner, O.; L. Persson, J.

Favourites:
ADD
Favourites:
ADD

Functionalized Graphene Oxide as Nanocarrier for Loading and Delivery of Ellagic Acid
pp. 4503-4512(10)
Authors: Kakran, M.; G. Sahoo, N.; Bao, H.; Pan, Y.; Li, L.

Favourites:
ADD

Recent Developments of Peptidomimetic HIV-1 Protease Inhibitors
pp. 4513-4537(25)
Authors: Qiu, X.; Liu, Z.-P.

Favourites:
ADD

Development of 5-Fluorouracil Derivatives as Anticancer Agents
pp. 4538-4556(19)
Authors: Pan, Xiaoyan; Wang, Chen; Wang, Fang; Li, Pengfei; Hu, Zhigang; Shan, Yuanyuan; Zhang, Jie

Favourites:
ADD

Phytosterols: Perspectives in Human Nutrition and Clinical Therapy
pp. 4557-4567(11)
Authors: P. Choudhary, S.; S. Tran, L.

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more